Janux Therapeutics, Inc. ($JANX)
Filing Information
| Accession Number | 0002050056-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 3, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
133,214
Total Value
$37,263.22
P&L
+inf% (+$1,833,290.10)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Sale | 2,714 | $13.73 | $37,263.22 | 23,286 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 2, 2026 | Grant/Award | 29,000 | $0.00 | $0.00 | 52,286 | Direct | โ | View Details | |
Chief Medical Officer | Stock option (right to buy) | Derivative | Jan 2, 2026 | Grant/Award | 101,500 | $0.00 | $0.00 | 101,500 | Direct | โ | View Details |